In support of the Global Liver Institute campaign for International NASH Day, NASHNET developed a groundbreaking white paper titled “Biomarkers for Diagnosing and Staging Nonalcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH): Current Perspectives and Potential Future Applications.”
The white paper sheds light on guideline-directed and optimal use of biomarkers to diagnose or stage NASH.
Special thanks to Novo Nordisk for sponsoring this white paper.
To read the full paper, please visit here.